Table 1.
Comp. | Biological Interpretation | Compounds in Group A | Compounds in Group B | VolSurf Interpretation |
---|---|---|---|---|
1 |
Classic growth factor signaling: (MAP and protein kinase signaling) |
Sulfonamides, antibiotics, carbonic anhydrase inhibitors |
Antipsychotic and antihistaminic compounds |
High lipophilicity |
2 |
DNA damage |
Contrast agents, antibiotics, |
DNA damaging agents, antimetabolites |
Strong lipophilic areas emphasized |
3 |
Stress response, mitochondrial and anabolic metabolism |
DNA damaging agents |
GPCR antagonists, ion channel blockers |
Polar interactions enriched |
4 |
Cytoskeleton, cell adhesion and migration |
GPCR liganda, macrocyclic cmpds and contrast agents |
Beta adrenergic agonists, other GPCR ligands |
N/A |
5 |
Differentiation, EMT, stemness |
NSAIDS, cAMP signaling promoting compounds |
HDAC Inhibitors, HDAC-like |
Significantly enriched with pharmacophoric features* |
6 |
Inflammatory and differentiation signaling |
N/A |
Protein synthesis inhibitors, anti-diabetics, cardiac glycosides |
Pharmacophoric features* |
7 |
GPCR and cytokine signaling |
N/A |
Cardiac glycosides, cephalosporins |
Pharmacophoric features* |
8 |
Growth factor and cell adhesion signaling |
Cardiac glycosides |
β-adrenergic agonists, Ca2+ channel blockers |
Integy-moment and significant pharmacophoric enriched* |
9 |
Amino acid and nitrogen metabolism |
Protein synthesis inhibitors |
Anti-diabetics |
Integy-moment and significant pharmacophoric enriched* |
10 | Cancer signaling | DNA damaging agents | Corticosteroids, ionophores | Size shape type descriptors |
The pharmacophoric enrichment analysis (marked with “*”) was carried out over VolSurf features (Additional file 5: VolSurf_Classification.xls) considered as a gold standard, and measuring enrichment of the list in a component by a hypergeometric test.